| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594403 | American Heart Journal | 2017 | 6 Pages |
Abstract
If we can demonstrate that the use of an ACE inhibitor or a BB can reduce the degree of TZB-induced cardiotoxicity, it is hoped that patients will receive complete and uninterrupted TZB therapy for breast cancer without compromising cardiac function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maya MD, PhD, Pamela MD, Angelina Fink, Jeffrey PhD,